Navigation Links
Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
Date:2/10/2012

ANAHEIM, Calif., Feb. 10, 2012  /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Leerink Swann Global Healthcare Conference to be held on February 15-16, 2012 in New York.  Steve Cartt, Executive Vice President and Chief Business Officer, is scheduled to present an overview of the Company on Thursday, February 16, 2012 at 2:30 p.m. ET. 

A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.  The replay will be available for 90 days after the event.

About Questcor                                                                                     

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product, Acthar, helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has appro
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Questcor Announces Third Quarter 2010 Earnings Release Date and Conference Call
2. Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index
3. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
4. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
7. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
8. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
9. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
10. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
11. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... IL (PRWEB) May 22, 2013 Alton Housing ... dated May 15, 2013 said that their presence has ... other bed bug sufferers avoid such big spending, My Cleaning ... inexpensively. , It was said in the report that ... exterminator, MCP related. Apart from that, its employees also attended ...
(Date:5/22/2013)... 22, 2013  Moderna Therapeutics, the pioneering company developing ... enable the in vivo production of therapeutic ... will join Moderna in early July as its ... a proven leader in the design and implementation of ... discovery to translation, clinical operations and commercial preparedness. John ...
(Date:5/21/2013)... Custom Learning Designs, Inc.(CLD) unveils ... using Tin Can API combined with its own ... a leading developer of training content and solutions ... , Tin Can API is a cost-effective ... trainers more accurately measure the Return on Education ...
(Date:5/21/2013)... The congress of the ERA-EDTA (European Renal Association ... congress in Europe on nephrology ... Istanbul to share their knowledge ... have been presented: / (1) Gupta, A ... REDUCES ESA USE" By SFP-iron administration, the ...
Breaking Biology Technology:Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3
... DIEGO, Oct. 23, 2008 Forest,Laboratories, Inc. ... today announced,that they have entered into a ... (PHX1149) in North America. Dutogliptin is,Phenomix, proprietary ... undergoing Phase 3,clinical development in Type 2 ...
... Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) announced today ... a poster presentation entitled "In Vivo Efficacy ... in,Nude Mice Bearing Human Melanoma Xenografts" at ... Cancer Therapeutics. SAIC-Frederick is,the prime contractor to ...
... 23 EntreMed, Inc.,(Nasdaq: ENMD ), ... treatment of cancer and inflammatory diseases, today,announced ... Aurora,A/angiogenesis kinase inhibitor, ENMD-2076. The data were ... Oncology, University of Colorado, at,the 20th EORTC-NCI-AACR ...
Cached Biology Technology:Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes 2Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes 3Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes 4Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium 2Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium 3EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model 2EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model 3
(Date:5/20/2013)... Boulder, Colo., USA New Geology ... 16 May 2013 cover a wide swath of ... tectonics, oceanography, geophysics, and paleobotany. Locations studied include ... mine at Alpi Apuane, Italy; Ukraine; Mars; and ... , 1. Rubies, jadeite, and plate tectonics;, ...
(Date:5/19/2013)... Researchers have engineered a strain of electricity-producing bacteria that ... donor and carbon dioxide as its sole source of ... report their findings at the 113th General Meeting of ... first result of current production solely on hydrogen," says ... with his co-authors are part of the Lovley Lab ...
(Date:5/18/2013)... The AGA Research Foundation is honored to announce the ... Digestive Cancer, which will support Andrew D. Rhim, MD, ... of Pennsylvania, Philadelphia, as he furthers his research on ... cancer progression. , "The AGA Research Foundation is humbled ... clinicians and AGA Legacy Society members," said Nicholas F. ...
Breaking Biology News(10 mins):New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... the quantity of a certain type of immune cell ... a bone marrow stem cell transplant will successfully restore ... a child. This research, by investigators at St. Jude ... , This finding could help physicians predict whether children ...
... that when dinosaurs died and became fossilized, soft ... into "rocks" through a gradual replacement of all ... North Carolina State University paleontologist, however, could literally ... Schweitzer, assistant professor of paleontology with a joint ...
... Hopkins scientists has,found the first clear evidence that ... to recognize and respond to a million,different proteins ... whose,only apparent function is to jump around in ... of the genetic material, and scientists,have suspected that ...
Cached Biology News:Circles Of DNA Might Help Predict Success Of Stem Cell Transplantation 2Circles Of DNA Might Help Predict Success Of Stem Cell Transplantation 3Circles Of DNA Might Help Predict Success Of Stem Cell Transplantation 4NC State scientist finds soft tissue in T. rex bones 2New therapy for HIV/AIDS eliminates needles and excessive toxicity 2New therapy for HIV/AIDS eliminates needles and excessive toxicity 3
Standard 2" and 3" Fiberboard Boxes can be sold separately or with 16, 25, 36, 49, 64, 81 or 100 cell dividers. Fiberboard boxes can also be ordered with corresponding freezer racks...
Although each Beacon 2000 System includes one preinstalled sample chamber (size specified at time of order), optional chambers are available and easily retrofit by the user....
... technology incorporating the sophisticated DirectDrive architecture ... new Varian NMR System is undeniably ... ,The Varian NMR System features parallel ... channel, providing pulse sequence programming power ...
... vitro cell labeling mix, 92.5 ... solution stabilized with 0.1% 2-mercaptoethanol ... 3,4-dicarboxylic acid. *Amino acid mixture ... containing l-[35S]Methionine and l-[35S]Cysteine. * ...
Biology Products: